Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2010
11/18/2010CA2761687A1 Nutritionally balanced standard tube feeding formula containing probiotics
11/18/2010CA2761655A1 Probiotic containing modules for tube feeding
11/18/2010CA2761627A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity
11/18/2010CA2761598A1 Complete liquid nutrition for children at the age of 1-10 years comprising probiotics
11/18/2010CA2761574A1 Oral nutritional supplement for children comprising probiotics
11/18/2010CA2761573A1 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
11/18/2010CA2761449A1 Oral nutritional supplement comprising probiotics
11/18/2010CA2761446A1 Infant and young children feeding formula comprising probiotics for infants and young children
11/18/2010CA2761444A1 Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
11/18/2010CA2761442A1 Non-replicating micro-organisms and their immune boosting effect
11/18/2010CA2761238A1 Prevention and treatment of allergic diarrhoea
11/18/2010CA2757759A1 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
11/17/2010EP2251344A1 Formulation of boronic acid compounds
11/17/2010EP2251341A1 Heterocyclic Janus kinase 3 inhibitors
11/17/2010EP2251037A1 KIM-1 antibodies for treatment of TH1/TH2-mediated conditions
11/17/2010EP2251022A1 Non-replicating micro-organisms and their immune boosting effect
11/17/2010EP2251021A1 Prevention and treatment of allergic diarrhoea
11/17/2010EP2250269A2 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
11/17/2010EP2250199A1 Engineered anti-tslpr antibodies
11/17/2010EP2250183A1 Immunostimulatory sirna molecules
11/17/2010EP2250165A1 Triazole oxadiazoles derivatives
11/17/2010EP2249865A2 Breaking immunological tolerance with a genetically encoded unnatural amino acid
11/17/2010EP2249855A1 Immunogenic peptides and their use in transplantation
11/17/2010EP2249854A1 Improved treatment and prophylaxis
11/17/2010EP2249849A1 Combination therapy comprising actinidia and steroids and uses thereof
11/17/2010EP2249846A2 Preparation comprising mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating rheumatoid arthritis.
11/17/2010EP2249845A2 Selective agonist of toll-like receptor 3
11/17/2010EP2249835A1 Methods using immunomodulatory compounds for modulating level of cd59
11/17/2010EP2249646A1 Dual pharmacophores - pde4-muscarinic antagonistics
11/17/2010CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound
11/17/2010CN101888989A Novel aryl potassium channel blockers and uses thereof
11/17/2010CN101886106A Method for extracting collagen peptide from fish scales
11/17/2010CN101885784A Method for producing glucomannan by liquid culture of konjac cells
11/17/2010CN101885769A Fully human antibody capable of specifically bonding CD4 and use thereof
11/17/2010CN101885731A Thiophene derivative
11/17/2010CN101884785A Enzymolysis ovalbumin compound oral liquid
11/17/2010CN101884781A Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplantation or graft versus host reaction of bone marrow transplantation
11/17/2010CN101884769A Traditional Chinese medicine for treating autoimmune thyroiditis and production method
11/17/2010CN101884726A Food therapy preparation for strengthening immunity based on theories of preventive treatment of disease and medicine food homology
11/17/2010CN101884703A Application of medicinal composition in preparation of autoimmune disease treatment medicaments
11/17/2010CN101884668A Composition for preventing and treating allergic rhinitis and preparation method thereof
11/17/2010CN101884635A Amino acid hypoglycemic capsule
11/17/2010CN101884628A Preparation method for fexofenadine hydrochloride-containing medicinal composition
11/17/2010CN101307109B Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use
11/17/2010CN101284061B Chinese herbal medicine formulations for promoting the yellow catfish growing
11/17/2010CN101167919B Medicine composition capable of promoting the growth of bone tissue and preparation technology and application thereof
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7834022 enzyme inhibitor for treating immune-related diseases, skin disorders, myeloid proliferative disorders, cancer; allograft rejection or graft versus host disease
11/16/2010US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia
11/16/2010US7833786 Anti-IL-6 antibodies, compositions, methods and uses
11/16/2010US7833538 using an immunostimulatory dinucleotide of formula CpG*, wherein C is a natural or non-natural pyrimidine nucleoside and G* is 7-deazaguanosine; for treating autoimmune disorders, such as autoimmune asthma; allergies
11/16/2010US7833537 administering isolated and purified T. suis helminthic parasite preparation free of human bacterial, mycobacterial and viral pathogens; treating inflammatory bowel disease, crohn's disease, and ulcerative colitis, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis
11/16/2010US7833527 Methods of treating psoriasis using IL-17 Receptor A antibodies
11/16/2010US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them
11/16/2010CA2523216C Recombinant alphavirus vectors
11/16/2010CA2487329C Process for the manufacture of quinoline derivatives
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2407316C Pet food composition for reducing inflammatory response in cats
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2342609C Adjuvant containing n-formyl methionyl peptides for vaccines
11/16/2010CA2333578C Adjuvant and vaccine compositions containing monophosphoryl lipid a
11/16/2010CA2311648C Ifnar2/ifn complex
11/16/2010CA2283462C Vectors having enhanced expression and methods of making and uses thereof
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/11/2010WO2010129959A1 Compositions and methods for the prevention and treatment of lupus nephritis using anti-dsdna germline antibodies
11/11/2010WO2010129917A2 Anti-cd100 antibodies and methods for using the same
11/11/2010WO2010129802A1 Inhibitors of jak
11/11/2010WO2010128949A1 A nutraceutical composition
11/11/2010WO2010128663A1 Interleukin-2 production inhibitor
11/11/2010WO2010128364A1 Method for the prevention or treatment of taxodiaceae pollen allergy
11/11/2010WO2010128303A1 Multi- valent adjuvant display
11/11/2010WO2010127558A1 Substituted benzoyl urea compounds, preparation methods and uses thereof
11/11/2010WO2010094733A3 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
11/11/2010WO2010092577A3 COMPLEMENT C3a DERIVED DIMERIC PEPTIDES AND USES THEREOF
11/11/2010US20100287637 Methods of blocking tissue destruction by autoreactive t cells
11/11/2010US20100287630 Models for vaccine assessment
11/11/2010US20100286269 Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents
11/11/2010US20100286266 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
11/11/2010US20100286255 Method for extracting secoisolariciresinol and dihydroquercetin from wood
11/11/2010US20100286239 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286191 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators
11/11/2010US20100286141 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010US20100286098 Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease
11/11/2010US20100286079 Composition comprising covalent conjugates of chitosan and an acidic drug and parenteral administration
11/11/2010US20100286072 Retro-inverso peptides derived from interleukin-6
11/11/2010US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions
11/11/2010US20100286054 Composition
11/11/2010US20100286048 Albumin Fusion Proteins
11/11/2010US20100286026 Novel protein
11/11/2010US20100285529 Feline granulocyte macrophage colony stimulating factor proteins
11/11/2010US20100285112 Methods of delivering oligonucleotides to immune cells
11/11/2010US20100285108 Method for therapeutic use
11/11/2010US20100285106 Multicomponent vaccine
11/11/2010US20100285072 Method for Producing Dendritic Cells
11/11/2010US20100285069 Meningococcal vaccine formulations
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1172